Chey Loveday

5.1k total citations
15 papers, 657 citations indexed

About

Chey Loveday is a scholar working on Genetics, Molecular Biology and Surgery. According to data from OpenAlex, Chey Loveday has authored 15 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 9 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Chey Loveday's work include Genomics and Rare Diseases (4 papers), Testicular diseases and treatments (4 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (3 papers). Chey Loveday is often cited by papers focused on Genomics and Rare Diseases (4 papers), Testicular diseases and treatments (4 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (3 papers). Chey Loveday collaborates with scholars based in United Kingdom, Australia and United States. Chey Loveday's co-authors include P Davey, Barbara Weller, Heather Loveday, Stephen Barrett, Robert Pratt, Anne Mulhall, P Harper, Mark H. Wilcox, Carol Pellowe and Clare Turnbull and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The American Journal of Human Genetics and Human Molecular Genetics.

In The Last Decade

Chey Loveday

13 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chey Loveday United Kingdom 8 246 233 93 88 80 15 657
Catherine M. Biggs Canada 16 107 0.4× 111 0.5× 212 2.3× 61 0.7× 81 1.0× 39 896
O. Nájera Mexico 9 138 0.6× 158 0.7× 85 0.9× 89 1.0× 77 1.0× 10 797
A Masi Italy 13 184 0.7× 60 0.3× 33 0.4× 188 2.1× 71 0.9× 25 655
Jennifer D. Possick United States 9 253 1.0× 40 0.2× 103 1.1× 237 2.7× 63 0.8× 24 1000
Maryam Motamedi Iran 11 151 0.6× 51 0.2× 69 0.7× 52 0.6× 139 1.7× 35 558
Amparo Escribano Spain 18 125 0.5× 203 0.9× 74 0.8× 1.1k 12.9× 185 2.3× 47 1.4k
Samuele Naviglio Italy 15 86 0.3× 191 0.8× 67 0.7× 48 0.5× 74 0.9× 45 648
Lorenz Grigull Germany 16 80 0.3× 148 0.6× 144 1.5× 75 0.9× 83 1.0× 56 745
Jihong Dai China 17 164 0.7× 32 0.1× 65 0.7× 352 4.0× 140 1.8× 62 794
Serap Aksoylar Türkiye 16 105 0.4× 81 0.3× 51 0.5× 45 0.5× 61 0.8× 47 603

Countries citing papers authored by Chey Loveday

Since Specialization
Citations

This map shows the geographic impact of Chey Loveday's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chey Loveday with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chey Loveday more than expected).

Fields of papers citing papers by Chey Loveday

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chey Loveday. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chey Loveday. The network helps show where Chey Loveday may publish in the future.

Co-authorship network of co-authors of Chey Loveday

This figure shows the co-authorship network connecting the top 25 collaborators of Chey Loveday. A scholar is included among the top collaborators of Chey Loveday based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chey Loveday. Chey Loveday is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Bandlamudi, Chaitanya, Chey Loveday, Miika Mehine, et al.. (2022). Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations. Annals of Oncology. 34(3). 215–227. 63 indexed citations
3.
4.
Brown, Derek W., Qing Lan, Nathaniel Rothman, et al.. (2021). Genetically Inferred Telomere Length and Testicular Germ Cell Tumor Risk. Cancer Epidemiology Biomarkers & Prevention. 30(6). 1275–1278. 3 indexed citations
5.
Çubuk, Cankut, Alice Garrett, Laura King, et al.. (2021). Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes. Genetics in Medicine. 23(11). 2096–2104. 42 indexed citations
6.
Loveday, Chey, Amit Sud, Kevin Litchfield, et al.. (2019). Runs of homozygosity and testicular cancer risk. Andrology. 7(4). 555–564. 4 indexed citations
7.
Loveday, Chey, Anna Zachariou, Lucy‐Ann Behan, et al.. (2019). EED and EZH2 constitutive variants: A study to expand the Cohen‐Gibson syndrome phenotype and contrast it with Weaver syndrome. American Journal of Medical Genetics Part A. 179(4). 588–594. 23 indexed citations
8.
Ostrowski, Philip J., Anna Zachariou, Chey Loveday, et al.. (2019). Null variants and deletions in BRWD3 cause an X‐linked syndrome of mild–moderate intellectual disability, macrocephaly, and obesity: A series of 17 patients. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 181(4). 638–643. 5 indexed citations
9.
Litchfield, Kevin, Chey Loveday, Max Levy, et al.. (2018). Large-scale Sequencing of Testicular Germ Cell Tumour (TGCT) Cases Excludes Major TGCT Predisposition Gene. European Urology. 73(6). 828–831. 44 indexed citations
10.
Loveday, Chey, Katherine Josephs, Daniel Chubb, et al.. (2018). p.Val804Met, the Most Frequent Pathogenic Mutation in RET, Confers a Very Low Lifetime Risk of Medullary Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 103(11). 4275–4282. 38 indexed citations
11.
Tatton‐Brown, Katrina, Chey Loveday, Shawn Yost, et al.. (2017). Mutations in Epigenetic Regulation Genes Are a Major Cause of Overgrowth with Intellectual Disability. The American Journal of Human Genetics. 100(5). 725–736. 128 indexed citations
12.
Loveday, Chey, Kevin Litchfield, Max Levy, et al.. (2017). Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer. Oncotarget. 9(16). 12630–12638. 6 indexed citations
13.
Loveday, Chey, Katrina Tatton‐Brown, Matthew Clarke, et al.. (2015). Mutations in the PP2A regulatory subunit B family genesPPP2R5B,PPP2R5CandPPP2R5Dcause human overgrowth. Human Molecular Genetics. 24(17). 4775–4779. 62 indexed citations
14.
Pratt, Robert, Carol Pellowe, Heather Loveday, et al.. (2001). The epic Project: Developing National Evidence-based Guidelines for Preventing Healthcare associated Infections. Journal of Hospital Infection. 47. S3–S4. 238 indexed citations
15.
Ferchal, F, et al.. (1994). AZT RESISTANCE AND DISEASE PROGRESSION IN THE CONCORDE TRIAL. AIDS. 8(Supplement 4). S5–S5.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine M. Biggs Breakdown of academic impact, for papers by O. Nájera Breakdown of academic impact, for papers by A Masi Breakdown of academic impact, for papers by Jennifer D. Possick Breakdown of academic impact, for papers by Maryam Motamedi Breakdown of academic impact, for papers by Amparo Escribano Breakdown of academic impact, for papers by Samuele Naviglio Breakdown of academic impact, for papers by Lorenz Grigull Breakdown of academic impact, for papers by Jihong Dai Breakdown of academic impact, for papers by Serap Aksoylar
Rankless by CCL
2026